Luo MN - Search Results

1

Podocytes are likely the therapeutic target of IgA nephropathy with isolated hematuria: Evidence from repeat renal biopsy.

Luo MN, Yin Y, Li S, Hao J, Yao C, Xu YZ, Liu HF, Yang L. Luo MN, et al. Front Pharmacol. 2023 Apr 7;14:1148553. doi: 10.3389/fphar.2023.1148553. eCollection 2023. Front Pharmacol. 2023. PMID: 37089927 Free PMC article.

2

Autophagy activation reduces renal tubular injury induced by urinary proteins.

Liu WJ, Luo MN, Tan J, Chen W, Huang LZ, Yang C, Pan Q, Li B, Liu HF. Liu WJ, et al. Among authors: luo mn. Autophagy. 2014 Feb;10(2):243-56. doi: 10.4161/auto.27004. Epub 2013 Nov 26. Autophagy. 2014. PMID: 24345797 Free PMC article.

3

Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy.

Luo MN, Yao CW, Xu BH, Xu YZ, Liu WJ, Feng YM, Tao JL, Liu HF. Luo MN, et al. Exp Ther Med. 2014 Mar;7(3):553-559. doi: 10.3892/etm.2013.1467. Epub 2013 Dec 31. Exp Ther Med. 2014. PMID: 24520244 Free PMC article.

4

The expression of renal Epstein-Barr virus markers in patients with lupus nephritis.

Yu XX, Yao CW, Tao JL, Yang C, Luo MN, Li SM, Liu HF. Yu XX, et al. Among authors: luo mn. Exp Ther Med. 2014 May;7(5):1135-1140. doi: 10.3892/etm.2014.1578. Epub 2014 Feb 24. Exp Ther Med. 2014. PMID: 24940399 Free PMC article.

5

IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal biopsy.

Luo MN, Pan Q, Huang ZQ, Li SM, Xu YZ, Liu HF. Luo MN, et al. Discov Med. 2020 Jul-Aug;30(159):19-25. Discov Med. 2020. PMID: 33357359 Free article.

6

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury.

Li Z, Liu Z, Luo M, Li X, Chen H, Gong S, Zhang M, Zhang Y, Liu H, Li X. Li Z, et al. Cell Death Discov. 2022 May 2;8(1):239. doi: 10.1038/s41420-022-01034-0. Cell Death Discov. 2022. PMID: 35501332 Free PMC article. Review.

7

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study.

Luo MN, Pan Q, Ye T, Li S, Yang L, Liu HF, Xu Y. Luo MN, et al. Front Pharmacol. 2023 Mar 14;14:1093442. doi: 10.3389/fphar.2023.1093442. eCollection 2023. Front Pharmacol. 2023. PMID: 36998610 Free PMC article.

8

Analysis of a complex nephrotic syndrome case with multiple pathological types defined by renal biopsy.

Li Y, Huang L, Jing K, Luo M, Xu Y. Li Y, et al. Minerva Med. 2024 May 9. doi: 10.23736/S0026-4806.24.09297-8. Online ahead of print. Minerva Med. 2024. PMID: 38727710 Free article. No abstract available.

9

Selenium nanoparticles alleviate renal ischemia/reperfusion injury by inhibiting ferritinophagy via the XBP1/NCOA4 pathway.

Zuo Z, Luo M, Liu Z, Liu T, Wang X, Huang X, Li S, Wu H, Pan Q, Chen T, Yang L, Liu HF. Zuo Z, et al. Cell Commun Signal. 2024 Jul 25;22(1):376. doi: 10.1186/s12964-024-01751-2. Cell Commun Signal. 2024. PMID: 39061070 Free PMC article.

10

A method based on interpretable machine learning for recognizing the intensity of human engagement intention.

Bi J, Hu FC, Wang YJ, Luo MN, He M. Bi J, et al. Among authors: luo mn. Sci Rep. 2023 Feb 13;13(1):2537. doi: 10.1038/s41598-023-29661-2. Sci Rep. 2023. PMID: 36781983 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters